Efficacy Of Intravesical Nadofaragene Firadenovec For Patients With Carcinoma In Situ (Cis), Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer (Nmibc): Longer-Term Follow-Up From The Phase Iii Trial

JOURNAL OF UROLOGY(2021)

引用 3|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要